Similar Posts
A Big Week for Psychedelic Stocks: 2 CEOs Step Down, MDMA Patents and a Phase 3 Trial
Compass Pathways and Small Pharma announce executive shakeup, Mydecine and Awakn push forward with new research
One Ayahuasca Ceremony Might Reset Mental Health
A single experience with the psychedelic South American brew called…
New Zealand Psychologist Assembles First Study Microdosing Cancer Patients with LSD
University of Auckland researcher hopes the psychedelic treatment will enhance the effect of psychotherapy, easing end-of-life distress in patients.
SABI Mind Releases Global Psychedelic Survey: The World’s Most Comprehensive Assessment of Global Psychedelic Use
SABI Mind announces the launch of the Global Psychedelic Survey (GPS) to provide English-speaking adults from around the globe with the opportunity to participate in the most extensive assessment of global psychedelic use to date.
Cybin Set to Measure Psychedelic Effects on the Brain Using Kernel Flow’s Revolutionary Technology
The technology may be more broadly used in the future for neuroscientific or physiological studies of brain activity during psychedelic use.
Psychedelic Business News Spotlight: March 19, 2021
This week in psychedelic business news, quick dissolve LSD, novel psychedelic molecules move into investigational studies, and more.